G

Grawe, Freba; Rosenberger, Natalie; Ingenerf, Maria; Beyer, Leonie; Eschbach, Ralf; Todica, Andrei; Seidensticker, Ricarda; Schmid-Tannwald, Christine; Cyran, Clemens C.; Ricke, Jens; Bartenstein, Peter; Auernhammer, Christoph. J.; Ruebenthaler, Johannes; Fabritius, Matthias P. (2023): Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs. Cancer Imaging, 23 (1). ISSN 1470-7330

M

Mansour, Nabeel; Heinrich, Kathrin; Zhang, Danmei; Winkelmann, Michael; Ingenerf, Maria; Gold, Lukas; Klambauer, Konstantin; Rudelius, Martina; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Ricke, Jens; Heinemann, Volker; Westphalen, C. Benedikt; Kunz, Wolfgang G. (2024): Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation. Cancer Imaging, 24 (1). ISSN 1470-7330

Mönch, Sebastian; Heimer, Maurice M.; Winkelmann, Michael; Guertler, Anne; Schlaak, Max; Tufman, Amanda; Ben Khaled, Najib; de Toni, Enrico; Westphalen, Christoph B.; von Bergwelt-Baildon, Michael; Dinkel, Julien; Kazmierczak, Philipp M.; Ingrisch, Michael; Mansour, Nabeel; Unterrainer, Marcus; Heinzerling, Lucie; Ricke, Jens; Kunz, Wolfgang G. (2023): Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors. Cancer Imaging, 23 (1). ISSN 1470-7330

W

Winkelmann, Michael; Blumenberg, Viktoria; Rejeski, Kai; Bücklein, Veit L.; Ingenerf, Maria; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. (2023): Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria. Cancer Imaging, 23 (1). ISSN 1470-7330

Ö

Öcal, Osman; Schinner, Regina; Schütte, Kerstin; de Toni, Enrico N.; Loewe, Christian; Delden, Otto van; Vandecaveye, Vincent; Gebauer, Bernhard; Zech, Christoph J.; Sengel, Christian; Bargellini, Irene; Gasbarrini, Antonio; Sangro, Bruno; Pech, Maciej; Malfertheiner, Peter; Ricke, Jens; Seidensticker, Max; Kettner, E.; Amthauer, H.; Cwikla, J.; Walecki, J.; Klümpen, H.; Schott, E.; Kolligs, F.; Rosmorduc, O.; Menu, Y.; Leroy, V.; Mayerle, J.; Trumm, C.; Bartenstein, P.; Reiser, M.; Berg, T.; Moche, M.; Bilbao, I.; Gossner, L.; Reimer, P.; Popovic, P.; Stabuc, B.; Piasecki, P.; Podgajny, Z.; Sacco, R.; Peck-Radosavljevic, M.; Lammer, J.; Maleux, G.; Verslype, C.; Rosenberg, C.; Nitsche, D.; Waldenberger, P.; Vergniol, J.; Cassinotto, C.; Yalcin, S.; Peynircioglu, B.; Zavaglia, C.; Rampoldi, A.; Tran, A.; Chevallier, P.; Anty, R.; Trautwein, C.; Kuhl, C.; Grazioli, L.; Vogl, T.; Trojan, J.; Bartolozzi, C.; Iezzi, R.; Bronowicki, J. P.; Palmer, D.; Evans, J.; Sharma, R.; Weir, G.; Hubner, R.; Basu, B.; Ross, P. (2022): Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib. Cancer Imaging, 22: 1. ISSN 1470-7330